Price
Financials
Standalone, Rs crore| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Sales | 46 | 19 | 26 | 0 | 0 | 11 | 16 |
| Expenses | 74 | 23 | 26 | 11 | 2 | 9 | 18 |
| Operating Profit | -28 | -5 | -0 | -11 | -2 | 2 | -2 |
| OPM % | -61% | -24% | -1.4% | -4,100% | -6,633% | 19% | -13% |
| Other Income | 46 | -2 | 1 | -42 | 0 | 0 | 0 |
| Interest | 3 | 5 | 5 | 4 | 12 | 13 | 15 |
| Depreciation | 3 | 3 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 12 | -14 | -7 | -59 | -16 | -14 | -19 |
| Tax % | 44% | -33% | -64% | 15% | 0% | 0% | 0% |
| Net Profit | 6 | -9 | -3 | -68 | -16 | -14 | -19 |
| EPS in Rs | 5.28 | -7.37 | -2.09 | -55.36 | -13.12 | -11.03 | -15.40 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | -3% | 296% | 48% | ||
| Compounded Profit Growth | % | % | 11% | -40% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | % | % | % |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves | -1 | -9 | -11 | -79 | -95 | -109 | -128 |
| Borrowings | 41 | 46 | 43 | 86 | 104 | 118 | 133 |
| Other Liabilities | 16 | 12 | 9 | 13 | 8 | 9 | 6 |
| Total Liabilities | 68 | 62 | 53 | 32 | 29 | 31 | 24 |
| Fixed Assets | 34 | 31 | 29 | 26 | 24 | 22 | 19 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 34 | 30 | 25 | 6 | 5 | 9 | 4 |
| Total Assets | 68 | 62 | 53 | 32 | 29 | 31 | 24 |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 20 | -6 | 6 | -40 | 2 | -1 | 1 |
| Cash from Investing Activity | -1 | 1 | 1 | 0 | 0 | -0 | 0 |
| Cash from Financing Activity | -18 | 4 | -6 | 39 | -2 | 1 | 0 |
| Net Cash Flow | 2 | -2 | 1 | -1 | -0 | 0 | 1 |
| Free Cash Flow | 19 | -6 | 6 | -40 | 2 | -1 | 1 |
| CFO/OP | -73% | 142% | -1,717% | 376% | -120% | -45% | -34% |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 100 | 190 | 90 | 42 | 365 | 59 | 4 |
| Inventory Days | 228 | 458 | 83 | 110 | 4,198 | 365 | 64 |
| Days Payable | 96 | 53 | 20 | 136 | 20,622 | 346 | 68 |
| Cash Conversion Cycle | 232 | 596 | 153 | 16 | -16,060 | 77 | 0 |
| Working Capital Days | 127 | 264 | 67 | -10,697 | -37,230 | -35 | -69 |
| ROCE % | -11% | -4% | -35% | -21% | -1% | -20% |
Fundamentals
Market Cap₹ Cr.
Current Price₹ 0.82
Book Value₹ -94.1
ROCE-20.5 %
ROE%
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)48%
Compounded Profit Growth (TTM)-40%
Standalone figures.
Valuation
P/B, 3-year average4.29x
Profitability
Operating margin (excl. other income)-4100.00%
Operating margin (incl. other income)-20419.23%
EBITDA margin-20419.23%
Pre-tax margin-22803.85%
Net profit margin-26126.92%
ROE205.97%
ROCE-176.22%
ROA-158.75%
ROE, 3-year average-9.14%
ROCE, 3-year average-65.77%
ROA, 3-year average-59.04%
ROIC (approx.)-343.04%
Tax rate-14.57%
Other income / net worth63.38%
Growth
Sales growth (latest year)-98.99%
Sales CAGR, 3 years-82.19%
Per share
EPS (TTM)Rs -55.36
EPS (latest year)Rs -55.36
EPS, 3-year averageRs -21.60
Book value per shareRs -54.56
Sales per shareRs 0.21
Cash flow per shareRs -33.00
Free cash flow per shareRs 0.81
Efficiency
Asset turnover0.01x
Fixed asset turnover0.01x
Inventory turnover3.81x
Inventory days96 days
Debtor days42 days
Debtors turnover8.67x
Creditor days68 days
Cash conversion cycle0 days
Working capital days-69 days
Leverage
Total debtRs 86 Cr
Cash and bankRs 0 Cr
Net debtRs 85 Cr
Debt to equity-1.28x
Interest coverage-14.32x
Owners' fund to total sources-208.11%
Debt to assets267.11%
Cash flow
Cash from Operating Activity (latest year)Rs -40 Cr
Cash from Investing Activity (latest year)Rs 0 Cr
Cash from Financing Activity (latest year)Rs 39 Cr
Net Cash Flow (latest year)Rs -1 Cr
Free cash flow (latest year)Rs 1 Cr
FCFE (approx.: FCF + change in debt)Rs 44 Cr
Statement figures
Net sales (TTM)Rs 0 Cr
Net sales (latest year)Rs 0 Cr
Operating profit excl. other income (latest year)Rs -11 Cr
Other income (TTM)Rs -42 Cr
EBITDA (TTM)Rs -53 Cr
PBDT (TTM)Rs -57 Cr
Profit before tax (TTM)Rs -59 Cr
Tax (latest year)Rs 9 Cr
Net profit (TTM)Rs -68 Cr
Net profit (latest year)Rs -68 Cr
Depreciation (TTM)Rs 2 Cr
Interest (TTM)Rs 4 Cr
Cost of goods sold (latest year)Rs 3 Cr
Total expenditure (latest year)Rs 11 Cr
Total income (latest year)Rs -42 Cr
Share capitalRs 12 Cr
ReservesRs -79 Cr
Shareholders' fundsRs -67 Cr
Total assetsRs 32 Cr
Net blockRs 26 Cr
ReceivablesRs 0 Cr
InventoryRs 1 Cr
Other liabilitiesRs 13 Cr
Shares outstanding (crore)1.23
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 2 of 8| serious | Negative equity Shareholders' equity is negative |
| explain | Debt up, profit down Borrowings up 100% while net profit fell in 2012 |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
No quarterly results published.
Activity
CompareNo listed peers in this industry.
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Polar Pharma India Ltd?
Polar Pharma India Ltd (523333) has a market capitalisation of Rs Cr. at the close.